Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.

Fulltext:
51591.pdf
Embargo:
until further notice
Size:
83.20Kb
Format:
PDF
Description:
publisher's version
Publication year
2007Source
Fertility and Sterility, 87, 1, (2007), pp. 223-226ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Gynaecology
Chemical Endocrinology
Health Evidence
Former Organization
Epidemiology, Biostatistics & HTA
Journal title
Fertility and Sterility
Volume
vol. 87
Issue
iss. 1
Page start
p. 223
Page end
p. 226
Subject
IGMD 6: Hormonal regulation; NCEBP 12: Human Reproduction; NCEBP 2: Evaluation of complex medical interventions; ONCOL 2: Age-related aspects of cancer; ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detection; UMCN 1.5: Interventional oncology; UMCN 5.2: Endocrinology and reproductionAbstract
Antimullerian hormone (AMH) and other markers of ovarian reserve were assessed to determine their predictive value with respect to treatment outcome. In a multivariate regression analysis, AMH was found to be predictive of the number of oocytes and the number of embryos, but not of embryo quality or the chance of a pregnancy, after IVF/ICSI.
This item appears in the following Collection(s)
- Academic publications [204860]
- Electronic publications [103173]
- Faculty of Medical Sciences [81031]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.